Debra Thoma Vallner, Ph.D.

Vice President, Development Operations

Debra Vallner, Ph.D. has been our Vice President of Development Operations since 2014 and has over thirty years of experience in drug development. Previously, Dr. Vallner has held senior leadership positions at Roche, Nektar Therapeutics, Exelixis, and InteKrin Therapeutics. Prior to joining eFFECTOR, Dr. Vallner has served as VP of Clinical Development for the Institute of OneWorld Health, and as VP of Clinical Operations for Anthera Pharmaceuticals and most recently for Anacor Pharmaceuticals. She holds a Ph.D. in Pharmacology and Toxicology from West Virginia University School of Medicine and an MBA from Golden Gate University.